Protein glycosylation in cancer biology: An overview

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 3, 1996, Pages

  DairOlio, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5' O (4 ACETAMIDO 3,6,7,8 TETRA O ACETYL 2,4 DIDEOXY 1 METHOXYCARBONYL GLYCERO ALPHA GALACTO OCTAPYRANOSYL) 5 FLUORO 2',3' ISOPROPYLIDENEURIDINE; ASPARAGINE LINKED OLIGOSACCHARIDE; BLOOD GROUP ABH ANTIGEN; CARBOHYDRATE ANTIGEN; CASTANOSPERMINE; ENZYME INHIBITOR; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE; POLYSIALIC ACID; SIALIC ACID; SIALYLTRANSFERASE; SWAINSONINE; TUNICAMYCIN; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ANTIGEN EXPRESSION; BLOOD GROUP LEWIS SYSTEM; CANCER CELL; CANCER INHIBITION; HUMAN; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; SIALYLATION;

EID: 0029744892     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (162)

1. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985;54:631-64.
2. Brockhausen I. Biosynthesis of O-glycans of the N-acetylgalactosamine cc-Ser/Thr linkage type. In: Montreuil J, Schachter H, Vliegenthart JFG, eds. Glycoproteim. Amsterdam: Eisevier, 1995:201-59.
3. Warren L, Bück CA, Tuszynski GP. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior. Biochim Biophys Acta 1978;516:97-127.
4. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985;314:53-7.
5. Brockhausen I. Clinical aspects of glycoprotein biosynthesis. Grit Rev Clin Lab Sei 1993;30:65-151.
6. Irimura T, Gonzalez R, Nicolson GL. Effect of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Cancer Res 1981;41:3411-18.
7. Humphries MJ, Matsumoto K, White SL, Olden K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc NatlAcad Sei USA 1986;83:1752-6.
8. Humphries MJ, Matsumoto K, White SL, Olden K. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res 1986; 46:5215-22.
9. Pulverer G, Beuth J, Ko HL, Yassin A, Ohshima Y, Roszkowski K, et al. Glycoprotein modification of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. J Cancer Res Clin Oncol 1988;114:217-20.
10. Sargent NSE, Price JE, Darling DL, Flynn MP, Tarin D. Effects of altering surface glycoprotein composition on metastatic colonization potential of murine mammary tumor cells. Br J Cancer 1987;55:21-8.
11. Dennis JW, Koch K, Beckner D. Inhibition of human HT-29 colon carcinoma growth in vitro and in vivo by swainsonine and human interferon-a2. J Natl Cancer Inst 1989;81:1028-33.
12. Dennis JW, Koch K.Yousefi S, Van der Eist I. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine. Cancer Res 1990;50:1867-72.
13. Humphries MJ, Matsumoto K, White SL, Molyneux RJ Olden K. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res 1988;48:1410-15.
14. Newton S A, White SL, Humphries MJ, Olden K. Swainsonine inhibition of spontaneous metastasis. J Natl Cancer Inst 1989;81:1024-8.
15. Dennis JW. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res 1986;46:5131-6.
16. Goss PE, Baptiste J, Fernandes B, Baker M Dennis JW. A phase I study of swainsonine in patients with advanced malignancies. Cancer Res 1994;54:1450-7.
17. Kijima-Suda I, Miyamoto Y, Toyoshima S, Itoh M, Osawa T. Inhibition of experimental metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res 1986;46:858-62.
18. Wagner HE, Thomas P, Wolf BC, Rapoza A, Steele G. Inhibition of sialic acid incorporation prevents hepatic métastases. Arch Surg 1990;125:351-4.
19. Dennis JW, Waller C, Timpl R, Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type IV and fibronectin. Nature 1982;300:274-6.
20. Kijima-Suda I, Miyazawa T, Itoh M, Toyoshima S, Osawa T. Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate. Cancer Res 1988;48:3728-32.
21. Gallagher JT, Morris A, Dexter TM. Identification of two binding sites for wheat-germ agglutinin on polylactosamine-type oligosaccharides. Biochem J 1985; 231:115-22.
22. Tao TW, Burger MM. Non-metastasizing variants selected from metastasizing melanoma cells. Nature 1977; 270:437-8.
23. Yogeeswaran G, Salk PL. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981;212:1514-16.
24. Dennis JW. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin. J Natl Cancer Insi 1985;74:111119.
25. Dennis JW. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants. Cancer Res 1986;46:4594-600.
26. Dennis JW, Carver JP, Schachter H. Asparagine-linked oligosaccharides in murine tumor cells: comparison of a WGA-resistant (WGAr) nonmetastatic mutant and a related WGA-sensitive (WGAS) metastatic line. J Cell Bio/ 1984;99:1034-44.
27. Dennis JW, Lafertè S, Fukuda M, Dell A, Carver J. Asn-linked oligosaccharides in lectin-resistant tumor cell mutants with varying metastatic potential. Eur J Biochem 1986;161:359-73.
28. Ishikawa M, Dennis JW, Man S, Kerbel RS. Isolation and characterization of spontaneous wheat germ agglutininresistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice. Cancer Res 1988;48:665-70.
29. Ishikawa M, Kerbel RS Characterization of a metastasisdeficient lectin-resistant human melanoma mutant. Int J Cancer 1989;43:134-9.
30. Irimura T, Tressler RJ, Nicolson GL. Sialoglycoproteins of murine RAW117 large cell lymphoma/lymphosarcoma sublines of various metastatic colonization properties. Exp Cell Res 1986;165:403-16.
31. Benedetto A, Elia G, Sala A, Belardelli F. Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutininresistant Friend leukemia cells. Inr J Cancer 1989;43:12633.
32. Collard JC, Schijven JF, Bikker A, La Riviere G, Bolscher JGM, Roos E. Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas. Cancer Res 1986;46:3521-7.
33. Morgenthaler J, Kemmner W, Brossmer R. Sialic aciddependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCTlloa and HCTllob. Biochem Bwphys Res Commun 1990;171:860-6.
34. Passaniti A, Hart GW. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J Rial Cheni 1988; 263:7591-603.
35. Jiang M, Passaniti A, Penno MB, Hart GW. Adrenal carcinoma tumor progression and penultimate cell surface oligosaccharides. Cancer Res 1992;52:2222-7.
36. Cornil I, Kerbel RS, Dennis JW. Tumor cell surface l,4-linked galactose binds to lectin(s) on microvascular endothelial cell and contributes to organ colonization. JCellBiol 1990;111:773-81.
37. Penno MB, Passaniti A, Fridman R, Hart GW, Jordan C, Kumar S, et al. In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells. Proc Natl Acad Sei USA 1989;86:6057-61.
38. Finne J, Makela PH. Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. JBiolChem 1985;260:1265-70.
39. Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 1988;240:53-7.
40. Acheson A, Sunshine JL, Rutishauser U. NCAM polysialic acid can regulate both cell-cell and cell-substratum interactions. JCe//w/1991;114:143-53.
41. Figaf ella-Branger DF, Durbec PL, Rougon GN. Differential spectrum of expression of neural cell adhesion molecule isoforms and LI adhesion molecules on human neuroectodermal tumors. Cancer Res 1990;50:6364-70.
42. Geck M, Muller EJ, Schol DJ, Figdor CG, Bock E, Bitter-Suermann D, et al. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res 1990;50:1102-6.
43. Livingston BD, Jacobs JL, Glick MC, Troy F. Extended polysialic acid chains (n > 55) in glycoproteins from human neuroblastoma cells. J Biol Client 1988; 263:9443-8.
44. Komminoth P, Roth J, Lackie PM, Bitter-Suermann D, Heitz PU. Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 1991;139:297-304.
45. Scheidegger EP, Lackie PM, Papay J, Roth J. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest 1994;70:95-106.
46. Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Ain J Swr£Par/z0/1994;18:399-411.
47. Roth J, Zuber C, Wagner P, Taatjes D, Weisgerber C, Heitz PU, et al. Reexpression of poly(sialic acid) units of the neural cell adhesion molecule inWilms tumors. Proc Xatl AcadSciUSA 1988;85:2999-3003.
48. Dall'Olio F, Malagolini N, Di Stefano G, Minni F, Marrano D, Serafini-Cessi F. Increased CMP-NeuAc:Gall,4GlcNAc-R a2,6 sialyltransferase activity in human colorectal cancer tissues. Int J Cancer 1989;44:434-9.
49. Sata T, Roth J, Zuber C, Stamm B, Heitz PU. Expression of cx2,6-linked sialic acid residues in neoplastic but not in normal human colonie mucosa. Am J Pathol 1991; 139:1435-48.
50. DalPOlio F, Trerè D. Expression of a2,6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin-conjugated Sambucus nigra agglutinin. Eur JHistochem 1993;37:257-65.
51. Yamashita K, Fukushima K, Sakiyama T, Murata F, Kuroki M, Matsuoka Y. Expression of Siaa2,6Gal l,4GlcNAc residues on sugar chains of glycoproteins including carcinoembryonic antigens in human colon adenocarcinoma: applications of Trichosanthes japonica agglutinin I for early diagnosis. Cancer Res 1995;5S: 1675-9.
52. Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F. Postnatal development of rat colon epithelial cells is associated with changes in the expression of l ,4-AT-acetylgalactosaminyltransferase involved in the synthesis of Sda antigen and of a2,6 sialyltransferase towards A'-acetyllactosamine. Biochem J 1990;270:51924.
53. Vertino-Bell A, Ren J, Black JD, Lau JTY. Developmental regulation of -galactoside a2,6-sialyltransferase in small intestine epithelium. Dcv Biol 1994;165:126-36.
54. Dall'Olio F, Malagolini N, Serafini-Cessi F. The expression of soluble and cell-bound oc2,6 sialyltransferase in human colonie carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation. Biochem BiophYs Res Commun 1992;"l84:1405-10.
55. Hakomori S, Patterson CM, Nudelman E, Sekiguchi KA. A monoclonal antibody directed to A'-acetylneuraminosyla2-6-galactosyl residue in gangliosides and glycoproteins. JBiolChem 1983;258:11819-22.
56. Nilsson O, Lindholm L, Holmgren J, Svennerholm L. Monoclonal antibodies raised against NeuAc2oneolactotetraosylceramide detect carcinoma-associated gangliosides. Biochim Biophys Acta 1985;835:577-83.
57. Easton EW, Bolscher JGM, van den Eijnden DH. Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. J Biol Chcm 1991 ;266:21674-80.
58. Le Marer N, Laudet V, Svensson EC, Cazlaris H, Van Hille B, Lafrou C, et al. The c.Ha-ras oncogene induces increased expression of -galactoside a2,6-sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiologv 1992;2:49-56.
59. Le Marer N, Stehelin D. High alpha-2,6-sialylation of A"-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. Glvcobiology 1995;5:219-26.
60. Gessner P, Riedl S, Quentmaier A, KemmnerW. Enhanced activity of CMP-NeuAc:Gall-4GlcNAc:cx2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett 1993;75:143-9.
61. Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F. a2,6-sialylation of A'-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth. lut J Cancer 1991 ; 47:291-7.
62. Bresalier RS, Rockwell RW, Dahiya R, Duh QY, Kim YS. Cell surface sialoprotein alterations in metastatic murine colon cancer cell line selected in an animal model for colon cancer metastasis. Cancer Res 1990;50:1299-307.
63. Piscatelli JJ, Cohen SA, Berenson CS, Lance P. Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line. Cliu Exf> Metastasis 1995;13:141-50.
64. Dall'Olio F, Malagolini N, Serafini-Cessi F. Enhanced CMP-NeuAc:Gall,4GlcNAc-R a2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines. lut J Cancer 1992; 50:325-30.
65. Takano R, Muchmore E, Dennis JW. Sialylation and malignant potential in tumor cell glycosylation mutants. Glvcobiology 1994;4:665-74.
66. Dall'Olio F, Chiricolo M, Lollini P, Lau JTY. Human colon cancer cell lines permanently expressing a2,6-sialylated sugar chains by transfection with rat -galactoside a2,6 sialyltransferase cDKA. Biochem Biophvs Res Commun 199'5;211;554-61.
67. Santer UV, Gilbert F, Glick MC. Change in glycosylation of membrane glycoproteins after transfection of NIH 3T3 with human tumor DNA. Cancer Res 1984;44:3730-5.
68. Collard JG, Van Beek WP, Janssen JWG, Schijven JF. Transfection by human oncogenes: Concomitant induction of tumorigenicity and tumor-associated membrane alterations, bit J Cancer 1985;35:207-14.
69. Yamashita K, Ohkura T, TachibanaY, Takasaki S, Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformants by hydrazinolysis. J Biol Ghent 1984;259:10834-40.
70. Pierce M, Arango J. Rous Sarcoma Virus-transformed baby hamster kidney cells express higher levels of asparaginelinked tri- and tetraantennary glycopeptides containing [GlcNAc-(l,6)Man-a(l,6)Man] and poly-A'-acetvllactosamine sequences than baby hamster kid'ney cells. J Biol Chem 1986;261:10772-7.
71. Dennis JW, Kosh K, Bryce DM, Breitman M. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene 1989;4:835-60.
72. Dennis JW, Lafertè S, Waghorne C, Breitman ML, Kerbel RS. l-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987; 236:582-5.
73. Lafertè S, Dennis JW. Purification of two glycoproteins expressing l-6branched Asn-linked oligosaccharides from metastatic tumor cells. Biochem J 1989;259:569-76.
74. Heffernan M, Yousefi S, Dennis JW. Molecular characterization of P2B/LAMP-1, a major protein target of a metastasis-associated oligosaccharide structure. Cancer Res 1989;49:6077-84.
75. Yagel S, Feinmesser R,Wafhorne C, Lala PK, Breitman ML Dennis JW. Evidence that l,6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int J Cancer 1989; 44:685-90.
76. Takano R, Nose M, Tetsuro N, Kyogoku M. Increase of l -6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am J Pathol 1990;137:1007-11.
77. Fernande B, Sagman U, Auger M, Demetrio M, Dennis JW. l-6 branched oligosaccharides as markers of tumor progression in human breast and colon neoplasia. Cancer Res 1991;51:718-23.
78. Yousefi S, Higgins E, Daoling Z, Pollex-Kruger A, Hindsgaul O, Dennis JW. Increased UDP-GlcNAc:Gall3GalNAc-R (GlcNAc to GalNAc) -l,6-7V-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. J Biol Chem 1991;266:1772-82.
79. Brockhausen I, Kuhns W, Schachter H, Malta KL, Sutherland DR, Baker MA. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDPGlcNAc:Gal3GalNAc
80. Saitoh O, Piller F, Fox RI, Fukuda M. T-lymphocytic leukemias express complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. Blood 1991;77:1491-9.
81. Fukuda M. Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy. Glycobiology 1991;l:347-56.
82. Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, et al. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. EurJ Biochem 1994;222:415-24.
83. Yang JM, Byrd JC, Siddiki BB, ChungYS, Okuno M, Sowa M, et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994;4:873-84.
84. Van den Eijnden DH, Koenderman AHL, Schiphorst WECM. Biosynthesis of blood group i-active polylactosaminoglycans. J Biol Chem 1988;263:12461-71.
85. Piller F, Cartron JP, Maranduba A, Veyrieres A, Leroy Y, Fournet B. Biosynthesis of blood group I antigens. J Biol Chem 1984;2S9:13385-90.
86. Gu J, Nishikawa A, Fujii S, Gasa S, Taniguchi N. Biosynthesis of blood group I and i antigens in rat tissues. J Biol Chem 1992;267:2994-9.
87. Fukuda M. Cell surface glycoconjugates as oncodifferentiation markers in hematopoietic cells. Biochim BiophysActa 1985;780:119-50.
88. Schuessler MH, Pintado S, Welt S, Real FX, Xu M, Melamed MR, et al. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreatic cancer. Int y Cancer 1991;47:180-7.
89. Itai S, Nishikata J, Takahashi N, Tanaka O, MatsubaraY, Hasegawa S, et al. Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers. Cancer Res 1990;50:7603-11.
90. Mizoguchi A, Takasaky S, Maeda S, Kobata A. Changes in asparagine-linked sugar chains of human promyelocytic leukemic cells (HL-60) during monocytoid differentiation and myeloid differentiation. J Biol Chem 1984;259:11949-57.
91. Youakim A, Romero PA, Yee K, Carlsson SR, Fukuda M, Herscovics A. Decrease in polylactosamine glycans associated with lysosomal membrane glycoproteins during differentiation of CaCo-2 human colonie adenocarcinoma cells. Cancer Res 1989;49:6889-95.
92. WatkinsWM. Biochemistry and genetics of the ABO, Lewis and P blood group systems. In: Harris H, Hirschlorm K, eds. Advances in human genetics. New York: Plenum Press, 1980:1-136.
93. Hakomori S. Aberrant glycosylation in tumors and tumorassociated carbohydrate antigens. Adv Cancer Res 1989; 52:257-331.
94. Stenersen TC, Debelsteen E. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions. APMIS 1992;100(Suppl 27):139-48.
95. Itzkowitz S. Carbohydrate changes in colon carcinoma. APMIS 1992;100(Suppl 27): 173-80.
96. 0rntoft TF. Carbohydrate changes in bladder carcinomas. APMIS 1992;100(Suppl27):181-7.
97. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-33.
98. Greenwell P, Yates AD, Watkins WM. UDP-Nacetylgalactosamine as a donor substrate for the glycosyltransferase encoded by the B gene at the human blood group ABO locus. Carbohydr Res 1986; 149:149-70
99. David L, Leitao D, Sobrinho-Simoes M, Bennet EP, White T, Mandel U, et al. Biosynthetic basis of incompatible histo-blood group antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res 1993;53:5494-500.
100. Yuan M, Itzkowitz SH, Palekar A, Shamsuddin AM, Phelps PC, Trump BF, et al. Distribution of blood group antigens A,B,H, Lewis3, and Lewisb, in human normal, fetal, and malignant colonie tissue. Cancer Res 1985; 45:4499-511.
101. Itzkowitz SH,Yuan M, Ferrel LD, Ratcliffe RM, Chung YS, Satake K, et al. Cancer-associated alterations of blood group antigen expression in the human pancreas. J NatL Cancer Inst 1987;79:425-34.
102. Okada Y, Arima T, Togawa K, Nagashima H, Jinno K, Moriwaki S, et al. Neoexpression of ABH and Lewis blood group antigens in human hepatocellular carcinomas. J Natl Cancer Inst 1987;78:19-28.
103. 0rntoft TF, Wolf H, Clausen H, Dabelsteen E, Hakomori S. Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas. IntJ Cancer 1989;43:774-80.
104. Mandel U, Langkilde NC, 0rntoft TF, HamiltonTherkildsen M, Karkov J, Reibel J, et al. Expression of histo-blood-group-gene-defmed glycosyltransferases in normal and malignant epithelia: correlation with a A/B-carbohydrate expression. Im J Cancer 1992;52:7-12.
105. Metoki R, Kakudo K, Tsuji Y, Teng N, Clausen H, Hakomori S. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. J Natl Cancer Inst 1989;81:1151-7.
106. Matsumoto H, Muramatsu H, Shimotakahara T, Yanagi M, Nishijima H, Mitani N, et al. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer 1993;72:75-81.
107. Gwin JL, Klein-Szanto AJ, Zhang SY, Agarwal P, Rogatko A, Keller SM. Loss of blood group antigen A in non-small cell lung cancer. Ann Surg Oncol 1994;1:423-7.
108. Jordon DA, Jagirdar J, Kaneko M. Blood group antigens, Lewis" and Lewis5 in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J ParAo/1989;135:931-7.
109. Hanish FG, Hanski C, Hasegawa A. Sialyl Lewis" antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonie adenoma-carcinoma sequence. Cancer Res 1992;52:3138-44.
110. Cooper HS, Malecha MJ, Bass C, Fagel PL, Steplewski Z. Expression of blood group antigens H-2, Ley, and sialylated-Lea in human colorectal carcinoma. Am J Pathol 1991;138:103-10.
111. Sakamoto J, Watanabe T, Tokumaru T, Takagi H, Nakazato H, Lloyd KO. Expression of Lewis3, Lewisb, Lewis", Lewisy, sialyl-Lewisa, and sialyl-Lewis" blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 1989;49:745-52.
112. Cordon-Cardo C, Reuter VE, Finstad CL, Sheinfels J, Lloyd KO, Fair WR, et al. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma. Cancer Res 1989;49:212-8.
113. Singhal AK, 0rntoft TF, Nudelman E, Nance S, Schibing L, Stroud MR, et al. Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 1990;50:1375-80.
114. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. JBiolChem 1982;257:14365-9.
115. Phillips ML, Nudelman E, Gaeta FCA, Ferez M, Singhal AK, Hakomori S, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Le". Science 1990;250:1130-2.
116. Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B. Recognition by ELAM-1 of the sialyl-Le" determinant on myeloid and tumor cells. Science 1990;250:1132-5.
117. Bergh EL, Robinson MK, Mansson O, Butcher EC, Magnani JL. A carbohydrate domain common to both sialyl Lea and sialyl Le" is recognized by the endothelial cell adhesion molecule ELAM-1. J Biol Chem 1991;266:14869-72.
118. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis" oligosaccharide. J Cell Biol 1992;117:895-902.
119. Dejana E, Martin-Padura I, Lauri D, Bernasconi S, Bani MR, Garofalo A, et al. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type 1 carbohydrate chain. Lab Invest 1992;66:324-30.
120. Kojima N, Handa K, NewmanW, Hakomori S. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys Res Commun 1992;182:1288-95.
121. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M. Contribution of carbohydrate antigens sialyl Lewis3 and sialyl Lewis" to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993;53:354-61.
122. Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM, Byers SW. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. IntJ Cancer 1995;60:426-31.
123. Hasegawa H, Watanabe M, Arisawa Y, Teramoto T, Kodaira S, Kitajima M. Carbohydrate antigens and liver metastasis in colorectal cancer. Jpn J Clin Oncol 1993; 23:336-41.
124. Ogawa J, Tsurumi T,Yamada S, Koide S, Shohtsu A. Blood vessel invasion and expression of sialyl Lewis" and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. Cancer 1994; 73:1177-83.
125. Ogawa J, Sano A, Inoue H, Koide S. Expression of Lewisrelated antigens and prognosis in stage I non-small cell lung carcinoma. Ann Thorac Surg 1995;59:412-5.
126. Kageshita T, Hirai S, Kimura T, Hanai N, Ohta S, Ono T. Association between sialyl Lewis3 expression and tumor progression in melanoma. Cancer Res 1995;S5:1748-51.
127. Nakasaki H, Mitomi T, Noto T, Ogoshi K, Hanaue H, Tanaka Y, et al. Mosaicism in the expression of tumorassociated carbohydrate antigens in human colonie and gastric cancers. Cancer Res 1989;49:3662-9.
128. Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori S, et al. Increased expression of sialyl-dimeric Lex antigen in liver métastases of human colorectal carcinoma. Cancer Res 1989;49:6883-8.
129. Matsushita Y, Nakamori S, Seftro EA, Hendrix MJC, Irimura T. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric Lex antigen. Exp Cell Res 1991;196:20-5.
130. Matsusako T, Muramatsu H, Shirahama T, Muramatsu T, Ohi Y Expression of a carbohydrate signal sialyl-dimeric Le" antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder. Biochem Biophys Res Commun 1991;181:1218-22.
131. Blasco E, Torrado J, Belloso L, Arocena F, Cuadrado E. T-antigen: a prognostic indicator of high recurrence index in transitional carcinoma of the bladder. Cancer 1988; 61:1091-5.
132. Coon J, Weinstein RS, Summers J. Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 1982;77:692-9.
133. Limas C, Lange P. T-antigen in normal and neoplastic urothelium. Cancer 1986;58:1236-45.
134. Summers JL, Coon JS, Ward RM, Falor WH, Mille AW III, Weinstein RS. Prognosis of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res 1983;43:934-9.
135. Nishiyama T, Matsumoto Y, Watanabe H, Fujiwara M, Sato S. Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient's clinical course. J NatL Cancer Inn 1987;78:1113-17.
136. Fenlon S, Ellis IO, Bell J, Todd JH, Elston CW, Blarney RW. Helix pomatia and Ulex europaeus lectin binding in human breast carcinoma. J Pathol 1987;152:169-76.
137. Leathern AJ, Brooks SA. Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet 1987; i: 1054-6.
138. Springer GF. Tn epitope Ç/V-acetyl-D-galactosamineoc-Oserine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 1989; 26:1-5.
139. Boland CR, Montgomery CK, Kim YS. Alteration in human colonie mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sei USA 1982;79:2051-5.
140. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, BigbeeWL, et al. Expression of Tn, sialosyl Tn and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
141. Yuan M, Itzkowitz SH, Boland CR, Kim YD, Tomita JT, Palekar A, et al. Comparison of T-antigen expression in normal, premalignant and malignant human colonie tissues using lectin and antibody immunohistochemistry. Cancer Res 1986;46:4841-7.
142. 0rntoft TF, Harving N, Langkilde NC. O-linked mucintype glycoproteins in normal and malignant colon mucosa: lack of T antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Im J Cancer 1990; 45:666-72.
143. Vavasseur F,Yang JM, Dole K, Paulsen H, Brockhausen I. Synthesis of O-glycan core 3: Characterization of UDP-
144. GlcNAc: GalNAc-R 3-N-acetylglucosaminyltransferase activity from colonie mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology 1995;5:351-7.
145. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990; 66:1960-6.
146. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, lijima H, Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 oc-A'-acetylgalactosaminyl (sialosylTn) epitope. Cancer Res 1988;48:2214-20.
147. Itzkowitz S, Kjeldsen T, Priera A, Hakomori S,Yang US, KimYS. Expression of Tn, sialosyl Tn, and T antigens in human pancreas. Gastroenterology 1991;100:1691-700.
148. Osako M,Yonezawa S, Siddiki B, Huang J, Ho JJ, KimYS. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 1993;71:2191-9.
149. Siddiki B, Ho JJ, Huang J, Byrd JC, Lau E, Yuan M, et al. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy. Int J Cancer 1993; 54:467-74.
150. IkedaY, Kuwano H, Baba K, Ikebe M, Matushima T, AdachiY, el al. Expression of sialyl-Tn antigen in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus. Cancer Res 1993;S3:1706-8.
151. Werther JL, Rivera-MacMurray S, Bruckner H, Tatematsu M, Itzkowitz SH. Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome. BrJ Cancer 1994;69:613-6.
152. Inoue M, Ton SM, Ogawa H, Tanizawa O. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am J Clin Palhol 1991;96:711-16.
153. Cho SH, Sahin A, Hortobagyi GN, Hittelman WN, Dhingra K. Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy. Cancer Res 1994; 54:6302-5.
154. Inoue M, Ogawa H, Tanizawa O, KobayashiY, Tsujimoto M, Tsujimura T. Immunodetection of sialyl-Tn antigen in normal, hyperplastic and cancerous tissues of the uterine endometrium. Virchows Arch A Pathol Anat Histoplathol 1991;418:157-62.
155. KakejiY, MaeharaY, Morita M, Matsukuma A, Furusawa M, iakahashi I, et al. Correlation between sialyl-Tn antigen and lymphatic metastasis in patients with Borrman type IV gastric carcinoma. BrJ Cancer 1995;71:191-5.
156. Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, i7 al. Tumor-associated sialylated antigens are constitutively expressed in normal human colonie mucosa. Cancer Res 1995;55:1869-74.
157. Jass JR, Allison LM, Edgar S. Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl-Tn shows crossreactivity with variants of normal colorectal goblet cell mucin. Pathology 1994;26:418-22.
158. Ogata S, Maimonis PJ, Itzkowitz SH. Mucin bearing the cancer-associated sialosyl-Tn antigen mediates inhibition of natural killer cell cytotoxicity. Cancer Res 1992; 52:4741-6.
159. Singhal A, Fohn M, Hakomori S. Induction of a-A'acetylgalactosamine-O-serine/threonine (Tn) antigenmediated cellular immune response for active immunotherapy in mice. Cancer Res 1991;51:1406-11.
160. O'Boyle KP, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, et al. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res 1992;52:5663-7.
161. MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, et al. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Itnmunol Immnnother 1993; 36:215-22.
162. Miles DW, Happerfield LC, Smith P, Gillibrand R, Bobrow LG, Gregory WM, et al. Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. BrJ Cancer 1994;70:1272-5.